98%
921
2 minutes
20
Ectopic breast tissue and male breast cancer are both very rare diseases with only a few reports in the literature. Here, we present the first case of ectopic male breast cancer in the perineum. The patient was a 70-year-old man with a palpable mass in the perineum. A wide local excision and inguinal lymph node dissection revealed invasive breast carcinoma of no special type involving the skin and subcutis, and inguinal lymph node metastases. Immunohistochemical staining showed that the tumor cells were strongly positive for estrogen and progesterone receptors and negative for human epidermal growth factor receptor 2. Moreover, no p53 overexpression was observed. Herein, the clinical and pathologic features, as well as a review of ectopic male breast cancer are discussed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744002 | PMC |
http://dx.doi.org/10.4048/jbc.2017.20.4.404 | DOI Listing |
JMIR Cancer
September 2025
Department of Health Outcomes and Biomedical Informatics, University of Florida, 1889 Museum Road, Suite 7000, Gainesville, FL, 32611, United States, 1 352 294-5969.
Background: Disparities in cancer burden between transgender and cisgender individuals remain an underexplored area of research.
Objective: This study aimed to examine the cumulative incidence and associated risk factors for cancer and precancerous conditions among transgender individuals compared with matched cisgender individuals.
Methods: We conducted a retrospective cohort study using patient-level electronic health record (EHR) data from the University of Florida Health Integrated Data Repository between 2012 and 2023.
J Infect Dev Ctries
August 2025
Scientific Research Centre for Public Health, University of Vlore "Ismail Qemali", Vlore, Albania.
Introduction: Despite the HPV vaccine's efficacy in cervical cancer prevention, cervical cancer ranks second in prevalence among women, following breast cancer. Various factors negatively impact HPV vaccination uptake, with parents' knowledge and attitudes being particularly crucial in this regard.
Methodology: A cross-sectional study was conducted between February and May 2023, targeting parents in northern Albania.
Palliat Med Rep
April 2025
Department of Oncology, King Faisal Specialist Hospital & Research Centre (KFSH&RC), Jeddah, Saudi Arabia.
Background And Aims: Palliative radiotherapy practice patterns have been reported to vary widely, with a notable underutilization of single fraction treatment schedules. This study aims to investigate the outcomes and care patterns among patients receiving palliative radiotherapy for advanced cancer at a high-volume institution in Saudi Arabia.
Materials And Methods: Electronic records were used to identify patients receiving palliative radiotherapy for advanced cancer between 2018 and 2023.
Sage Open Pediatr
September 2025
The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Objective: To report the incidence and survival patterns for children, adolescents, and young adults (CAYA) cancer survivors over the past 20 years.
Methods: CAYA (under 25 years old) cancer survivors from 17 Surveillance, Epidemiology, and End Results (SEER) registries from 2000 to 2020 were analyzed. A joinpoint regression model was used to analyze the incidence and 5-year survival rate.
Case Rep Pathol
August 2025
Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.
Encapsulated papillary carcinoma (EPC) is an invasive carcinoma which shows papillary architecture within a thickened fibrous capsule. Multiple studies have shown that this tumor follows an indolent course with excellent prognosis, and as such, it is recommended that it be staged as in situ lesions. It is an uncommonly encountered tumor most often diagnosed in postmenopausal females.
View Article and Find Full Text PDF